• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

    5/3/24 5:57:39 AM ET
    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Computer Manufacturing
    Technology
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AAPL alert in real time by email

    Shares of Apple Inc. (NASDAQ:AAPL) rose sharply in today's pre-market trading after the company reported better reported better-than-expected results for its second quarter.

    The company announced a $110-billion stock buyback program and a one-penny-per-share increase in its quarterly dividend.

    Apple shares jumped 5.9% to $183.24 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Vaxxinity, Inc. (NASDAQ:VAXX) gained 45.8% to $0.1519 in pre-market trading after falling 9% on Thursday. Vaxxinity recently announced its intention to voluntarily delist and deregister its Class A common stock.
    • El Pollo Loco Holdings, Inc. (NASDAQ:LOCO) gained 23.1% to $10.59 in pre-market trading after the company reported better-than-expected first-quarter results.
    • AXT, Inc. (NASDAQ:AXTI) rose 23.8% to $3.75 in today's pre-market trading after the company reported better-than-expected first-quarter financial results.
    • Jaguar Health, Inc. (NASDAQ:JAGX) jumped 20.7% to $0.3540 in pre-market trading after surging 30% on Thursday.
    • Ardelyx, Inc. (NASDAQ:ARDX) shares gained 19.2% to $8.09 in pre-market trading after the company reported better-than-expected first-quarter financial results.
    • OneSpan Inc. (NASDAQ:OSPN) shares gained 18.6% to $13.00 in pre-market trading after the company reported better-than-expected first-quarter adjusted EPS and sales.
    • Rapid Micro Biosystems Inc (NASDAQ:RPID) shares rose 16.2% to $1.15 in pre-market trading.
    • The OLB Group, Inc. (NASDAQ:OLB) shares gained 19.8% to $0.5636 in pre-market trading after gaining 12% on Thursday. The company announced its shareholders approve a 1-for-10 reverse split.
    • Amgen Inc. (NASDAQ:AMGN) shares rose 14.2% to $318.01 in pre-market trading after the company reported better-than-expected first-quarter financial results. Also, the company announced a $50 million milestone payment from Royalty Pharma.

    Losers

    • NanoVibronix, Inc. (NASDAQ:NAOV) fell 44.8% to $0.3988 in pre-market trading after gaining 7% on Thursday.
    • Sprout Social, Inc. (NASDAQ:SPT) shares declined 25.2% to $36.00 in pre-market trading after the company reported worse-than-expected first-quarter revenue results.
    • Marin Software Incorporated (NASDAQ:MRIN) fell 19.4% to $2.54 in pre-market trading after the company reported a year-over-year decrease on first-quarter revenue results.
    • Stem, Inc. (NYSE:STEM) shares fell 18.7% to $1.55 in pre-market trading after the company reported worse-than-expected first-quarter financial results and cut its FY24 revenue guidance.
    • Terran Orbital Corporation (NYSE:LLAP) shares fell 18.5% to $1.05 in pre-market trading fter Lockheed Martin withdrew its buyout proposal.
    • Cloudflare, Inc. (NYSE:NET) fell 14% to $76.50 pre-market trading after the company reported first-quarter financial results and issued FY24 revenue guidance below estimates.
    • Trupanion, Inc. (NASDAQ:TRUP) shares declined 13% to $20.68 in pre-market trading following first-quarter results.
    • BigBear.ai Holdings, Inc. (NYSE:BBAI) shares fell 12.1% to $1.52 in pre-market trading after the company reported worse-than-expected first-quarter financial results.
    • Expedia Group, Inc. (NASDAQ:EXPE) shares declined 10.1% to $121.92 in pre-market trading after the company lowered its full-year guidance.
    • Fortinet, Inc. (NASDAQ:FTNT) fell 8.3% to $59.81 pre-market trading after the company reported its first-quarter financial results.

    Now Read This: Investor Sentiment Increases Ahead Of Jobs Report, Dow Jumps Over 300 Points

    Get the next $AAPL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAPL
    $AMGN
    $ARDX
    $AXTI

    CompanyDatePrice TargetRatingAnalyst
    Amgen Inc.
    $AMGN
    4/21/2026$366.00Hold
    Canaccord Genuity
    Apple Inc.
    $AAPL
    4/17/2026Neutral → Outperform
    BNP Paribas Exane
    Cloudflare Inc.
    $NET
    4/15/2026$222.00Neutral → Overweight
    Piper Sandler
    Apple Inc.
    $AAPL
    4/14/2026$320.00 → $325.00Buy
    BofA Securities
    Expedia Group Inc.
    $EXPE
    3/30/2026$300.00Hold → Buy
    Jefferies
    Apple Inc.
    $AAPL
    3/23/2026$325.00 → $320.00Buy
    BofA Securities
    El Pollo Loco Holdings Inc.
    $LOCO
    3/13/2026$14.00Hold → Buy
    The Benchmark Company
    Amgen Inc.
    $AMGN
    3/10/2026$350.00Hold
    Jefferies
    More analyst ratings

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    SEC Filings

    View All

    SEC Form DEF 14A filed by Stem Inc.

    DEF 14A - STEM, INC. (0001758766) (Filer)

    4/24/26 4:19:03 PM ET
    $STEM
    Industrial Machinery/Components
    Miscellaneous

    SEC Form DEF 14A filed by OneSpan Inc.

    DEF 14A - OneSpan Inc. (0001044777) (Filer)

    4/23/26 4:03:27 PM ET
    $OSPN
    EDP Services
    Technology

    Expedia Group Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Expedia Group, Inc. (0001324424) (Filer)

    4/23/26 9:00:50 AM ET
    $EXPE
    Transportation Services
    Consumer Discretionary

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REPATHA issued to AMGEN INC

    Submission status for AMGEN INC's drug REPATHA (SUPPL-44) with active ingredient EVOLOCUMAB has changed to 'Approval' on 11/20/2024. Application Category: BLA, Application Number: 125522, Application Classification:

    11/21/24 12:43:07 PM ET
    $AMGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    September 17, 2024 - FDA Roundup: September 17, 2024

    For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a

    9/17/24 2:34:22 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    September 12, 2024 - FDA Authorizes First Over-the-Counter Hearing Aid Software

    For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea

    9/12/24 10:58:17 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS

    THOUSAND OAKS, Calif., April 24, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2026 financial results on Thursday, April 30, 2026, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.The webcast, as with other selected presentatio

    4/24/26 4:01:00 PM ET
    $AMGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    AXT Announces Exercise of Over-Allotment Option in Public Offering of Common Stock

    AXT, Inc. (NASDAQ:AXTI) ("AXT" or the "Company"), a leading manufacturer of compound semiconductor wafer substrates, announced today that, in connection with its recently completed underwritten public offering of 8,560,311 shares of common stock, the underwriters have exercised their over-allotment option to purchase an additional 1,284,046 shares of common stock at a price to the public of $64.25 for additional gross proceeds of approximately $82.5 million, before deducting underwriting discounts and commissions and other offering expenses. As previously announced, the Company intends to use the net proceeds from the offering primarily to financially support our subsidiary Beijing Tongme

    4/24/26 12:00:00 PM ET
    $AXTI
    Semiconductors
    Technology

    Tradr Launches Leveraged ETFs on AXTI, CPNG, MPWR and STX

    Listings cover stocks involved in trending themes such as data storage and AI compute infrastructure Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched four new leveraged ETFs on single stocks. The Cboe-listed funds seek to deliver two times long (200%) the daily performance of a specific underlying stock. Three of the four ETFs are first-to-market strategies. The following ETFs are expected to open for trading today: Tradr 2X Long AXTI Daily ETF (Cboe: AXTX) – tracks AXT Inc. (NASDAQ:AXTI) Tradr 2X Long CPNG Daily ETF (Cboe: CPNX) – tracks Coupang Inc. (NYSE:CPNG) Tradr 2X Long MPWR Daily ETF (Cboe: MPWX) – tracks Monol

    4/24/26 6:46:00 AM ET
    $AXTI
    $CPNG
    $MPWR
    Semiconductors
    Technology
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Amgen with a new price target

    Canaccord Genuity initiated coverage of Amgen with a rating of Hold and set a new price target of $366.00

    4/21/26 7:31:29 AM ET
    $AMGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Apple upgraded by BNP Paribas Exane

    BNP Paribas Exane upgraded Apple from Neutral to Outperform

    4/17/26 8:01:37 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    Cloudflare upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Cloudflare from Neutral to Overweight and set a new price target of $222.00

    4/15/26 8:04:21 AM ET
    $NET
    Computer Software: Prepackaged Software
    Technology

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Zenner Marc bought $34,782 worth of shares (3,300 units at $10.54), increasing direct ownership by 4% to 83,208 units (SEC Form 4)

    4 - OneSpan Inc. (0001044777) (Issuer)

    3/4/26 4:30:16 PM ET
    $OSPN
    EDP Services
    Technology

    Director Mott David M bought $1,946,331 worth of shares (333,333 units at $5.84), increasing direct ownership by 11% to 3,302,918 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    2/23/26 9:01:11 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO Barretto Ryan Paul bought $1,002,621 worth of shares (93,984 units at $10.67), increasing direct ownership by 12% to 875,256 units (SEC Form 4)

    4 - Sprout Social, Inc. (0001517375) (Issuer)

    1/13/26 4:01:19 PM ET
    $SPT
    Computer Software: Prepackaged Software
    Technology

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Zatlyn Michelle

    4 - Cloudflare, Inc. (0001477333) (Issuer)

    4/22/26 7:55:38 PM ET
    $NET
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Ettenberg Felecia

    3 - ARDELYX, INC. (0001437402) (Issuer)

    4/22/26 4:04:27 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Ohlgart Christiane

    4 - Fortinet, Inc. (0001262039) (Issuer)

    4/20/26 4:26:34 PM ET
    $FTNT
    Computer peripheral equipment
    Technology

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Leadership Updates

    Live Leadership Updates

    View All

    Expedia Group Appoints Derek Andersen as Chief Financial Officer

    Expedia Group, Inc. (NASDAQ:EXPE) today announced that Derek Andersen has been appointed Chief Financial Officer, effective May 11, 2026. As CFO, Mr. Andersen will lead Expedia Group's global finance organization and report to Chief Executive Officer Ariane Gorin. He succeeds Scott Schenkel, who is stepping down from the role of CFO after strengthening the company's financial foundation and supporting margin expansion over the last 16 months. Mr. Schenkel will stay on through Expedia Group's first quarter earnings call on May 7, 2026, before departing the company on May 16, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026

    4/23/26 9:00:00 AM ET
    $EXPE
    Transportation Services
    Consumer Discretionary

    AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER

    Organizational Changes Further Emphasize Integration of Biology and TechnologyTHOUSAND OAKS, Calif., April 22, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the retirement of David M. Reese, M.D., executive vice president and Chief Technology Officer, effective June 30, 2026. Reese joined Amgen in 2005 as a clinical development leader in oncology and later served as executive vice president of Research and Development (R&D) from 2018 to 2023. During his tenure, he led approvals of numerous innovative medicines and biosimilars, advanced a robust pipeline of potential new therapies and strengthened discovery research capabilities. As inaugural chief technology officer, Reese encoura

    4/22/26 4:00:00 PM ET
    $AMGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

    WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Felecia W. Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer (CLO). She will oversee Ardelyx's legal, compliance, regulatory, and government affairs operations. Ms. Ettenberg succeeds Elizabeth Grammer, who has chosen to retire after an extraordinary 16-year career at the company. "I am thrilled to welcome Felecia as our new Chief Legal Officer," said Mik

    4/20/26 8:00:00 AM ET
    $ARDX
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/10/24 4:15:32 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    $AAPL
    $AMGN
    $ARDX
    $AXTI
    Financials

    Live finance-specific insights

    View All

    AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS

    THOUSAND OAKS, Calif., April 24, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2026 financial results on Thursday, April 30, 2026, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.The webcast, as with other selected presentatio

    4/24/26 4:01:00 PM ET
    $AMGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BigBear.ai to Report First Quarter 2026 Results on May 5, 2026

    BigBear.ai (NYSE:BBAI), a specialized defense technology company, providing mission-ready AI for national security and travel & trade customers, today announced that it will publish its first quarter earnings release on Tuesday, May 5 at approximately 4:15 pm ET and will host an earnings call at 4:30 pm ET. The earnings release will be accessible on the Company's investor relations website: https://ir.bigbear.ai. Additional details on the earnings call will be made available on the investor relations website on May 5, 2026. About BigBear.ai BigBear.ai is a specialized defense technology company, developing and deploying mission-ready AI solutions and services. Customers and partners rel

    4/21/26 4:15:00 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Trupanion Announces First Quarter 2026 Earnings Release and Conference Call

    SEATTLE, April 16, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2026 first quarter after the market closes on Thursday, April 30, 2026. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. Participants can a

    4/16/26 4:15:00 PM ET
    $TRUP
    Medical Specialities
    Health Care